Article Details

Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation

Retrieved on: 2023-09-15 18:12:49

Tags for this article:

Click the tags to see associated articles and topics

Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation. View article details on hiswai:

Excerpt

Remdesivir (RDV) was the first fast-tracked FDA approved treatment drug for COVID-19. RDV acts as an antiviral ribonucleoside (adenosine) analogue ...

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up